NCT04710368View on ClinicalTrials.gov

Effect of Evolocumab on Coronary Plaque Characteristics

PHASE4CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

October 28, 2022

Study Completion Date

November 6, 2023

Conditions
Coronary Artery Disease
Interventions
DRUG

Evolocumab Injections

Administered on day 1 (the day of the first treatment) and through week 26 with a personal injector or prefilled auto injector/pens.

Trial Locations (1)

10029

Mount Sinai Hospital, New York

All Listed Sponsors
lead

Annapoorna Kini

OTHER